[ad_1]
NEW YORK, Feb. 10, 2022 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) between May 28, 2021 and November 262021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2022.
SO WHAT: If you purchased Fennec Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Fennec Pharmaceuticals class action, go http://www.rosenlegal.com/cases-register-1926.htmlhttp://www.rosenlegal.com/cases-register-1961.html or call Phillip Kim,…
Full story available on Benzinga.com
[ad_2]
Source link
